<unk>  is a renal-urologic agent that is FDA approved for the treatment of and prevention of cystine (kidney) stone formation in patients with severe homozygous cystinuria.   Common adverse reactions include nausea, vomiting, abdominal pain, diarrhea, impairment in taste and smell, rash and pruritis.
Tiopronin
Iotrolan
Orciprenaline
Bevantolol
Alvimopan
Hexoprenaline
Levocabastine
Cyclobenzaprine